# A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B

> **NCT07635186** · PHASE2 · RECRUITING · sponsor: **Ausper Biopharma Co., Ltd.** · enrollment: 320 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** AHB-137
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07635186
- **Lead sponsor:** Ausper Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-05
- **Primary completion:** 2027-06-20
- **Final completion:** 2028-06-20
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2026-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07635186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07635186, "A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07635186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*